Phase 3 Study of Afinitor for Tuberous Sclerosis Complex - ONA
Links shared publicly online about this topic.
- 162total visits
Phase 3 Study of Afinitor for Tuberous Sclerosis Complex - ONA
View full resource at oncologynurseadvisor.com
Tags: Kidney Cancer Medication, Phase 3 Clinical Trial, Afinitor, Novartis
Most Recently Shared on July 8, 2011 at 3:11 pm By:
Phase 3 Study of Afinitor for Tuberous Sclerosis Complex http://goo.gl/fb/o4VDf
Novartis Drug Afinitor® Effective In Patients With Non-Cancerous Kidney Tumors Associated With TSC In Phase III Trial
medicalnewstoday.com — “A Phase III study of Afinitor® (everolimus) tablets* in patients with non-cancerous kidney tumors, or angiomyolipomas, associated with tuberous sclerosis complex (TSC) met its primary endpoint” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2011 at 8:05 am By:
Novartis Drug Afinitor® Effective In Patients With Non-Cancerous Kidney Tumors Associated With TSC In Phase III Trial http://mnt.to/3ZRM
Phase 3 Study of Afinitor for Tuberous Sclerosis Complex - MPR
empr.com — “Novartis announced results from its Phase 3 EXIST-1 study of Afinitor (everolimus) for the treatment of patients with subependymal giant cell astrocytomas (SEGAs) associated with tuberous sclerosis complex (TSC).” View full resource at empr.com
Most Recently Shared on July 8, 2011 at 3:11 pm By:
MPR News: Phase 3 Study of Afinitor for Tuberous Sclerosis Complex: Novartis announced results from its Phase 3 ... http://bit.ly/roAtDP
Advertisement
